The wrapup of the J-DAVID trial.
The J-DAVID Randomized Clinical Trial Visual Abstract
Aakash Shingada stepped up with a visual abstract for this week’s NephJC Chat.
Background
This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.
Background
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
Background
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
